Learn more about Sadiqa Mahmood

Author Bio

Sadiqa Mahmood

As Senior Vice President of Medical Affairs at Health Catalyst, Sadiqa Mahmood, oversees the organization’s healthcare and life sciences business in the U.S., U.K., Europe, and Asia. Dr. Mahmood’s work focuses on reshaping healthcare delivery and addressing areas of high unmet need for therapeutic development through application of real-world data and evidence. Dr. Mahmood is an active startup mentor, and advisor to healthcare organizations and global policy makers. She has been invited to share her work with notable organizations including Veterans Affairs Boston Healthcare System and Ministry of Health Singapore. Dr. Mahmood is a dental surgeon and holds a master’s degree in public health from the Harvard School of Public Health. Dr. Mahmood is passionate about improving patient outcomes. She has spent her career at the intersection of medicine, policy, technology, and analytics. Previously, she led clinical analytics, quality and safety, value-based contracting, and population health across healthcare organizations, including the Dana-Farber Cancer Institute, Partners HealthCare System, and Boston Medical Center. Dr. Mahmood has been an advocate of collaborative learning systems in healthcare and has steered cross-industry multi-stakeholder national and global collaborations to drive healthcare innovation.

Read articles by Sadiqa Mahmood

Insights

Alyssa Antonopoulos
Adem Albayrak
Sadiqa Mahmood
Elia Stupka, PhD

Data-Driven Precision Medicine: A Must-Have for the Next-Generation of Personalized Care

Under a precision medicine approach, clinicians, academics, and pharma and biotech researchers and regulators aim to deliver the right drug for the right patient at the right time. Data, however, can present a challenge to precision medicine goals due to gaps in clinical care, research, and drug development when organizations don’t have the ability to capture and report on relevant real-world data. With the right systems to collect and share clinical and molecular data, the healthcare industry can realize the full benefits of precision medicine.